ROS-responsive nanozyme hydrogel reprograms repair signaling networks in radiation-induced skin injury

Radiation-induced skin injury (RISI) is a common radiotherapy complication, characterized by excessive accumulation of reactive oxygen species (ROS) and disruption of the wound-healing microenvironment. Here, we report a ROS-responsive hydrogel incorporating ultrasmall Cu 5.4 O nanoparticles as ROS-regulating nanozymes, designated Cu 5.4 O@PVA/B/Gel. Embedded in a dynamic polymer network, the hydrogel enables ROS-triggered nanoparticle release and antioxidant activity under oxidative conditions. In vitro, Cu 5.4 O@PVA/B/Gel reduced oxidative stress and attenuated inflammation and apoptosis-related responses while promoting cell migration following irradiation. In a RISI mouse model, the hydrogel promoted wound closure, enhanced angiogenesis and vascular maturation, and improved collagen organization and extracellular matrix remodeling. Proteomic analysis and molecular validation revealed treatment-associated alterations in HIF-1- and NF-κB-related signaling, along with changes in markers of oxidative stress, inflammation, apoptosis, angiogenesis, and fibrosis-related responses. Functional perturbation experiments using HIF-1α knockdown and TNF-α stimulation further supported the involvement of HIF-1 and NF-κB signaling in the therapeutic response. Moreover, Cu 5.4 O@PVA/B/Gel reduced CD86⁺F4/80⁺ macrophages while increasing CD206⁺F4/80⁺ macrophages, indicating a shift toward an M2-like phenotype. These findings demonstrate that Cu 5.4 O@PVA/B/Gel enables ROS-responsive modulation of the irradiated skin microenvironment by coordinating multiple repair-associated processes. More broadly, this work highlights a design strategy for integrating ROS-responsive nanozyme release, catalytic antioxidant activity, and coordinated regulation of tissue repair within a single therapeutic platform for radiation-induced injury. Schematic illustration of the fabrication, ROS-responsive release, and therapeutic mechanisms of the Cu 5.4 O@PVA/B/Gel hydrogel in RISI

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-09-29
DOI
https://doi.org/10.1186/s12951-026-05089-4
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

ROS-responsive nanozyme hydrogel reprograms repair signaling networks in radiation-induced skin injury

Ying Xin, Jincai Lv, Zining Tan, Jinlong Wei et al.
Journal of Nanobiotechnology
Nanoplatforms for cancer theranostics
article

ROS-responsive nanozyme hydrogel reprograms repair signaling networks in radiation-induced skin injury

Ying Xin, Jincai Lv, Zining Tan, Jinlong Wei, Yuwei Huang, Jinwen Zhao, Wei Liu, Xin Jiang
article en

Abstract

Radiation-induced skin injury (RISI) is a common radiotherapy complication, characterized by excessive accumulation of reactive oxygen species (ROS) and disruption of the wound-healing microenvironment. Here, we report a ROS-responsive hydrogel incorporating ultrasmall Cu 5.4 O nanoparticles as ROS-regulating nanozymes, designated Cu 5.4 O@PVA/B/Gel. Embedded in a dynamic polymer network, the hydrogel enables ROS-triggered nanoparticle release and antioxidant activity under oxidative conditions. In vitro, Cu 5.4 O@PVA/B/Gel reduced oxidative stress and attenuated inflammation and apoptosis-related responses while promoting cell migration following irradiation. In a RISI mouse model, the hydrogel promoted wound closure, enhanced angiogenesis and vascular maturation, and improved collagen organization and extracellular matrix remodeling. Proteomic analysis and molecular validation revealed treatment-associated alterations in HIF-1- and NF-κB-related signaling, along with changes in markers of oxidative stress, inflammation, apoptosis, angiogenesis, and fibrosis-related responses. Functional perturbation experiments using HIF-1α knockdown and TNF-α stimulation further supported the involvement of HIF-1 and NF-κB signaling in the therapeutic response. Moreover, Cu 5.4 O@PVA/B/Gel reduced CD86⁺F4/80⁺ macrophages while increasing CD206⁺F4/80⁺ macrophages, indicating a shift toward an M2-like phenotype. These findings demonstrate that Cu 5.4 O@PVA/B/Gel enables ROS-responsive modulation of the irradiated skin microenvironment by coordinating multiple repair-associated processes. More broadly, this work highlights a design strategy for integrating ROS-responsive nanozyme release, catalytic antioxidant activity, and coordinated regulation of tissue repair within a single therapeutic platform for radiation-induced injury. Schematic illustration of the fabrication, ROS-responsive release, and therapeutic mechanisms of the Cu 5.4 O@PVA/B/Gel hydrogel in RISI

Journal of Nanobiotechnology
Jilin University (CN), First Hospital of Jilin University (CN), Ministry of Education (KN)
Openalex Percentile: Top 22%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.